HyRec, NCT01716949: Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer |
|
|
| Recruiting | 1/2 | 59 | Europe | Radiotherapy, Hyperthermia, 5-Fluorouracil, all brands of 5-Fluorouracil are allowed, Capecitabine, all brands of Capecitabine are allowed, Oxaliplatin, all brands of oxaliplatin are allowed | University of Erlangen-Nürnberg Medical School | Rectal Cancer | 06/22 | 06/23 | | |
